Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

Superior vena cava syndrome

Jonathan F Wan, Andrea Bezjak

Hematology/oncology Clinics of North America 2010, 24 (3): 501-13

Superior vena cava syndrome is a common complication of malignancy. The epidemiology, presentation, and diagnostic evaluation of patients presenting with the syndrome are reviewed. Management options including chemotherapy and radiation therapy and the role of endovascular stents are discussed along with the evidence for each of the therapeutic options.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Superior vena cava syndrome. Jonathan F Wan, Andrea Bezjak Emergency Medicine Clinics of North America 2009, 27 (2): 243-55

Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. N P Nguyen, T L Borok, J Welsh, V Vinh-Hung Thorax 2009, 64 (2): 174-8

[Endovascular treatment of superior vena cava syndrome]. Michel Bergoeing R, Renato Mertens M, Francisco Valdés E, Albrecht Krämer Sch, Manuel Alvarez Z, Pablo Bertin C, Rodrigo Sagüés C, Eric Orellana U, Héctor Galindo A, Jeannette Vergara G, Magaly Valdebenito C Revista Médica de Chile 2006, 134 (7): 827-32

Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer. A Urruticoechea, R Mesía, J Domínguez, C Falo, E Escalante, A Montes, C Sancho, F Cardenal, M Majem, J R Germà Lung Cancer: Journal of the International Association for the Study of Lung Cancer 2004, 43 (2): 209-14

Wallstent endovascular prosthesis for the treatment of superior vena cava syndrome. S Sasano, T Onuki, M Mae, K Oyama, M Sakuraba, S Nitta Japanese Journal of Thoracic and Cardiovascular Surgery 2001, 49 (3): 165-70

Endovascular stenting in neoplastic superior vena cava syndrome prior to chemotherapy or radiotherapy. E Bierdrager, L E H Lampmann, P N M Lohle, C M Schoemaker, J H E M Schijen, F M L H G Palmen, C van der Heul Netherlands Journal of Medicine 2005, 63 (1): 20-3

[Endovascular therapy of superior vena cava syndrome: clinical case]. C Boza, R Mertens, F Valdés, A Kramer, L Mariné, J Vergara Revista Médica de Chile 2001, 129 (4): 421-6

Intravascular stents in the management of acute superior vena cava obstruction of benign etiology. J Rosenblum, J Leef, R Messersmith, M Tomiak, F Bech JPEN. Journal of Parenteral and Enteral Nutrition 1994, 18 (4): 362-6

Superior vena cava syndrome associated with childhood malignancy: analysis of 24 cases. L Ingram, G K Rivera, D N Shapiro Medical and Pediatric Oncology 1990, 18 (6): 476-81

Causes and management of superior vena cava syndrome. C P Escalante Oncology (Williston Park, NY) 1993, 7 (6): 61-8; discussion 71-2, 75-7

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Superior vena cava syndrome

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips